PRECISE-IHCC Conference 2024
)
Jointly organised by Precision Health Research, Singapore (PRECISE) and the International Health Cohorts Consortium (IHCC), the conference will bring together some 600 thought leaders, clinicians, scientists, biotechs, and patient advocacy associations from across the world who are at the forefront of precision medicine and public health innovation.
Themed “From Cohorts to Clinics: The New Landscape of Global Healthcare”, the conference seeks to address the challenges and opportunities in translating advances in precision medicine into tangible enhancements in patient care and reshape the landscape of modern healthcare. It also aims to catalyse and promote cross-population cohort research and design cross-cohort pilot projects to address various global challenges.
The three-day conference will be held on-site from 21 to 23 August 2024 in Singapore.
Please also visit us at Booth #03 if you are able to attend the event.
Lunch session talk
The Era of Complete Genomes
Date & Time: 22 August 2024, Thursday | 1.25pm – 1.50pm(SST)
Venue: Meeting Room (Break out 2), One Farrer Hotel | Level 6
Address: 1 Farrer Park Station Road Singapore 217562
Meet the Speaker
Comprehensive genomes that include information about not only single nucleotide variants and other small variants, but also structural variants, copy number variations, repeats, and epigenetic markers like methylation, are changing the landscape of genomics. From new reference datasets that are more representative of human genetic diversity to the integration of more complete genomic and multi-omic data into clinical research, the community is now generating ultra-rich sequencing data without having to compromise on scale. In this workshop, we will showcase examples demonstrating the value of nanopore sequencing to identify novel and known variants and gain insights into the biology of 100s to 1000s of samples.
Comprehensive genomes that include information about not only single nucleotide variants and other small variants, but also structural variants, copy number variations, repeats, and epigenetic markers like methylation, are changing the landscape of genomics. From new reference datasets that are more representative of human genetic diversity to the integration of more complete genomic and multi-omic data into clinical research, the community is now generating ultra-rich sequencing data without having to compromise on scale. In this workshop, we will showcase examples demonstrating the value of nanopore sequencing to identify novel and known variants and gain insights into the biology of 100s to 1000s of samples.
)
Cora Vacher, Associate Director, Segment Marketing, Oxford Nanopore Technologies
